Proteomics Intl Labs Ltd has released a press release.
PromarkerD application for Australian MBS to be resubmitted
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Distribution agreement for PromarkerD in Britain extended
- December 2022 Quarterly Activities Report and Appendix 4C
- Letter of intent with Sonic Healthcare USA extended
- CPT PLA reimbursement code approved in US for PromarkerD
- UK NICE publishes Medtech Innovation Briefing on PromarkerD
Later from Proteomics International Laboratories
- New endometriosis test presented at international conference
- Proteomics renews ISO 13485 and ISO 17025 accreditations
- March 2023 Quarterly Activities Report and Appendix 4C
- Canagliflozin lowers PromarkerD DKD risk prediction scores
- World Endometriosis Congress - New diagnostic test showcased
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories